Comparative efficacy and safety of cabozantinib for malignant tumors: a systematic review and meta-analysis

Objectives To provide a more comprehensive understanding of the efficacy and safety profile of cabozantinib versus placebo in malignant tumors, we conducted a systematic review and meta-analysis. This involved analyzing a collection of published randomized controlled trials to assess the outcomes.